Every single day, approximately 17.5 United States military veterans take their own lives. That is one death every 82 minutes; a relentless, years-long toll that has persisted despite billions of federal dollars poured into veteran mental health programs, expanded psychiatric staffing at VA hospitals, and a sweeping expansion of psychotropic drug prescriptions handed to men and women who served their country in uniform.^[1]^[2]

The numbers demand a question that few in Washington or the mainstream psychiatric establishment appear willing to ask: What if the treatment itself is part of the problem?

That is the central question driving a body of investigative reporting and advocacy work published by the Citizens Commission on Human Rights Florida (CCHR), a watchdog group that monitors and exposes what it describes as psychiatric human rights violations. Their reporting on veterans and active-duty military paints a deeply troubling picture; one of a population under enormous psychological stress being funneled into a drug-centric care model that, the evidence suggests, may be accelerating the very crisis it claims to treat.

Florida’s Veterans: A Population in Crisis

Florida is home to approximately 1.38 million veterans (roughly 12% of the state’s adult population) the second-largest veteran population in the nation, trailing only Texas. It is also a state where the crisis of veteran suicide cuts particularly deep.^[3]^[4]

Nationally, the veteran suicide rate stands at 35.2 per 100,000; the highest level recorded since 2018, according to the VA’s 2025 National Veteran Suicide Prevention Annual Report, the most comprehensive analysis of its kind. For non-veteran U.S. adults, the comparable rate is 16.9 per 100,000; meaning veterans die by suicide at roughly twice the rate of their civilian counterparts.^[2]^[5]^[6]^[7]

In Florida specifically, the disparity is even starker. According to state-level analysis, Florida veterans die by suicide at a rate 2.6 times higher than the general population; a Florida-specific figure that significantly exceeds the national veteran-to-civilian ratio. The state lost 540 veterans to suicide in 2022, the most recent year for which Florida-specific data is available; approximately 1.5 veterans every single day. Florida ranks second only to Texas in total veteran suicides.^[8]

These are not outliers. They are a mirror of a national catastrophe. And yet, year after year, the institutional response has been the same: more diagnoses, more prescriptions, more of the same psychiatric interventions whose track record, scrutinized carefully, raises serious alarms.

The Prescription Pipeline: What Is Actually Being Given to Veterans?

When veterans return from combat zones carrying the psychological wounds of war (nightmares, flashbacks, emotional numbing, hypervigilance0 they are most commonly diagnosed with Post-Traumatic Stress Disorder, or PTSD. That diagnosis, CCHR’s reporting makes clear, has become less a clinical roadmap to healing and more a gateway to aggressive pharmaceutical treatment.

According to peer-reviewed research published in clinical literature, approximately 78% of veterans diagnosed with PTSD are prescribed at least one psychotropic medication. Among those receiving psychotropic drugs, antidepressants —specifically SSRIs and SNRIs — account for between 80% and 88% of all such prescriptions. A substantial minority; documented in VA research at between 15% and 23%, depending on the study population and time period; are also prescribed antipsychotics, many of which carry the FDA’s most stringent “black box” warnings, the agency’s highest level of safety alert.

Those black box warnings exist for a reason. The U.S. Food and Drug Administration has mandated that antidepressant labels explicitly warn about increased risks of suicidal thoughts and behaviors; particularly in young adults. The agency expanded these warnings in 2007 to specifically cover individuals aged 18 to 24, recommending close monitoring for abrupt changes in mood, behavior, or ideation during early treatment.

Veterans are, disproportionately, young adults. They are, by the nature of their service, already at heightened psychological risk. Among veterans aged 18 to 34, the VA’s 2025 report documents a suicide rate of 47.9 per 100,000; far exceeding the overall veteran average. The question that CCHR’s reporting presses with urgency: why are the very drugs flagged by the FDA for increasing suicidal risk being administered en masse to the population most at risk for suicide?^[1]

Billions Spent. The Rate Still Rising.

The Department of Defense and the Veterans Administration have not been passive in the face of the veteran suicide crisis. They have spent billions. Mental health staffing has expanded. Outreach programs have multiplied.

The results are, at best, mixed. In 2023, 6,398 veterans died by suicide nationally; 44 fewer than in 2022, a modest and fragile decline. But the suicide rate per 100,000 veterans actually rose from 34.7 in 2022 to 35.2 in 2023 (its highest point since 2018) because the veteran population itself is shrinking faster than the death toll. Put another way: fewer veterans exist, but a higher proportion of them are dying by suicide. From 2001 to 2023, the overall veteran population decreased by 29.8%, while the suicide rate climbed 69.3% for male veterans and 64.1% for female veterans.^[6]^[9]^[10]^[2]^[1]

Critically, the VA’s own 2025 report reveals that 61% of veterans who died by suicide in 2023 were not receiving VA health care in the last year of their lives. This fact cuts in two directions: it suggests the VA’s direct-care programs may be reaching those most in need; but it also raises urgent questions about what is happening to the vast majority of veterans being treated, or not treated, outside the VA system entirely.^[9]^[10]

CCHR’s reporting documents this grim paradox: the more the psychiatric establishment has embedded itself in veteran care, the more entrenched the underlying crisis has become. Critics of this system argue that when the primary tool in the mental health toolkit is a prescription pad, the outcome is predictably, tragically limited.

Shock Therapy’s Quiet Comeback — at the VA

Perhaps the most alarming thread in CCHR’s veteran coverage concerns electroconvulsive therapy, or ECT; a procedure commonly known as electroshock therapy. Despite its controversial history, ECT has experienced a quiet resurgence within the VA system.

CCHR’s reporting reveals that the Veterans Administration has allocated significant funding for ECT equipment and programming, even as veteran suicide rates (particularly among younger veterans) remain at crisis levels. The procedure, which passes electrical currents through the brain to induce seizures, has been associated in reported cases and medical literature with lasting memory loss, cognitive disruption, and, sometimes, death.

The organization has organized protests and public campaigns calling for investigations into the VA’s ECT programs, describing the procedure as an inadequately studied and dangerous intervention being applied to some of the nation’s most vulnerable people. Advocates and some medical professionals argue that the absence of rigorous, long-term outcome data demonstrating that ECT reduces veteran suicide should, at minimum, prompt far greater caution than is currently exercised.

A History of Experimentation: Soldiers as Test Subjects

To understand the present, CCHR’s reporting argues, one must reckon honestly with the past. The organization documents a troubling historical pattern in which military populations have been treated by the psychiatrists involved as convenient experimental subjects.

Mid-20th century military psychiatrists described armed forces communities in clinical literature as near-ideal settings for controlled psychiatric experimentation. During and after World War II, soldiers suffering psychological trauma were subjected to electroshock treatments, insulin shock therapy, and an array of mind-altering pharmaceutical compounds; often without meaningful informed consent and frequently without clear therapeutic benefit.

CCHR presents this history not as a relic, but as a warning; arguing that today’s mass prescription of psychotropic drugs to active-duty personnel and veterans, backed by a diagnostic manual (the DSM) whose categories are determined by committee consensus rather than biological testing, represents a continuation of the same pattern under a more clinical veneer.

Violence, Shootings, and the Drug Question

The consequences CCHR documents extend beyond suicide. In several high-profile cases of violence involving active-duty military or veterans, including a mass shooting at a Florida Navy installation and a deadly attack on law enforcement officers by a veteran in Louisiana, the organization has raised pointed questions about the role of prescribed psychiatric medications.

In each case noted, the perpetrators carried documented psychiatric diagnoses, including PTSD, and were under pharmaceutical treatment at or near the time of the incidents. Known side effects of certain antidepressants and antipsychotics include agitation, aggression, impulsivity, and emotional disinhibition. CCHR argues that the consistent failure to rigorously investigate whether psychotropic medications may have been contributing factors in these tragedies represents a dangerous blind spot, one that protects pharmaceutical interests at the expense of public safety.

Honoring Service While Demanding Accountability

The Florida chapter of CCHR has also worked to honor veterans directly, hosting events on occasions such as Purple Heart Day to recognize those wounded in service while simultaneously using those platforms to inform veterans and their families of their rights in psychiatric settings. Their advocacy work covers the risks of involuntary commitment under Florida’s Baker Act, the right to seek non-psychiatric medical evaluations, and the availability of non-drug treatment alternatives.

Their message to veterans and their families is consistent: ask questions, know your rights, and do not assume that a psychiatric label or a prescription is either inevitable or the only path forward.

The Reckoning That Has Not Come

The statistics, updated to the VA’s most current data, are not in dispute. 17.5 veterans per day — one every 82 minutes — nationally. In Florida: roughly 1.5 veterans every day, at a rate 2.6 times higher than the state’s general population. Nationally, 6,398 veterans died by suicide in 2023 alone — and since 2001, that cumulative toll has surpassed 140,000 lives. The suicide rate per 100,000 veterans has hit its highest level in five years.^[2]^[8]^[1]

A system built on diagnoses that lack biological confirmation, and treatments whose own manufacturers warn can increase suicidal risk, has presided over decades of unrelenting loss. The VA’s own data shows that veterans not connected to its care system are dying at dramatically higher rates, 71.1% higher age-adjusted rate increases for male veterans without recent VA care versus those within it, pointing to a massive gap between what the system promises and what it delivers.^[1]

CCHR’s body of work on veterans is, at its core, a demand for a reckoning that has not yet arrived; a congressional investigation into the relationship between psychotropic drug prescribing and veteran suicide, an honest accounting of ECT’s risks within the VA, and a fundamental reimagining of veteran mental health care that moves beyond pills and shock toward approaches grounded in documented evidence and genuine respect for the men and women who served.

The veterans who survived combat deserve no less. The more than 140,000 who have died by suicide since 2001 deserved far more than they received.^[8]

SOURCES: